Literature DB >> 6713729

Systemic antibody deficiency in patients without serum immunoglobulin deficiency or with selective IgA deficiency.

M A French, G Harrison.   

Abstract

Serum IgG tetanus toxoid antibody (IgGTTab) concentrations were measured in patients with chronic chest infections or recurrent acute chest infections following immunization and compared with results obtained in a group of 43 controls. Apart from selective IgA deficiency in some patients, all had normal or high serum immunoglobulins. Using an enzyme linked immunosorbent assay (ELISA) for IgG TTab, antibody was present following one immunization in all controls who had previously been immunized and following two immunizations in those not previously immunized. Ninety-seven and a half per cent of controls had a serum antibody concentration of greater than 4 micrograms/ml. Following the same immunization schedule, eight of 45 (18%) patients with chronic chest infections and three of 11 (27%) patients with recurrent acute infections had a serum IgG TTab of less than 4 micrograms/ml. The three patients with a low IgG TTab concentration and recurrent acute infections all had selective IgA deficiency. Two of these patients have benefited from injections of normal human immunoglobulin. It is suggested that systemic antibody deficiency as a cause of chronic or recurrent respiratory tract infections cannot be excluded by measuring serum immunoglobulin concentrations alone and that it is of value to measure antibody responses following immunization.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6713729      PMCID: PMC1535964     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

Review 1.  The biology and detection of immune complexes.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Pulmonary host defenses. II. Interaction of respiratory antibodies with Pseudomonas aeruginosa and alveolar macrophages.

Authors:  H Y Reynolds; R E Thompson
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

3.  Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa.

Authors:  H Y Reynolds; R E Thompson
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

4.  Antibody deficiency syndrome: a case with normal immunoglobulin levels.

Authors:  T E Blecher; J F Soothill; M A Voyce; W H Walker
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

5.  Mechanism of mucosal immunity to viral infections in gammaA immunoglobulin-deficiency syndromes.

Authors:  P L Ogra; P R Coppola; M H MacGillivray; J L Dzierba
Journal:  Proc Soc Exp Biol Med       Date:  1974-03

6.  Immunological abnormalities in bronchiectasis with chronic bronchial suppuration.

Authors:  A M Hilton; L Doyle
Journal:  Br J Dis Chest       Date:  1978-07

7.  Antibody deficiency with normal immunoglobulins.

Authors:  C Rothbach; J Nagel; B Rabin; P Fireman
Journal:  J Pediatr       Date:  1979-02       Impact factor: 4.406

8.  Immunological status of patients with recurrent chest infections.

Authors:  M Zembala; T Adamek-Guzik; B Mytar; A Szczeklik
Journal:  Lung       Date:  1978       Impact factor: 2.584

9.  Bovine antigens and the formation of circulating immune complexes in selective immunoglobulin A deficiency.

Authors:  C Cunningham-Rundles; W E Brandeis; R A Good; N K Day
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

10.  Immunologic studies in patients with recurrent bronchopulmonary infections.

Authors:  E Kagan; C L Soskolne; S Zwi; S Hurwitz; G M Maier; T Ipp; A R Rabson
Journal:  Am Rev Respir Dis       Date:  1975-04
View more
  13 in total

1.  Immunoglobulin subclass distribution of human anti-carbohydrate antibodies: aberrant pattern in IgA-deficient donors.

Authors:  L Hammarström; M A Persson; C I Smith
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

2.  Antibody responses to tetanus toxoid in patients with primary biliary cirrhosis.

Authors:  D Watmough; M A French; D R Triger
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

3.  Chronic cough in a hospital population; its relationship to atopy and defects in host defence.

Authors:  H M Lewis; M Haeney; J Jeacock; H Thomas
Journal:  Arch Dis Child       Date:  1989-11       Impact factor: 3.791

4.  Enhanced IgG1 and IgG3 responses to pneumococcal polysaccharides in isolated IgA deficiency.

Authors:  D M Roberton; J Björkander; J Henrichsen; T Söderström; L A Hanson
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

5.  Evaluation of test immunisation in the assessment of antibody deficiency syndromes.

Authors:  A D Webster; A A Latif; M K Brenner; D Bird
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-23

6.  The IgG4 subclass is associated with a low affinity antibody response to tetanus toxoid in man.

Authors:  M E Devey; K M Bleasdale; M A French; G Harrison
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

7.  Lymphadenopathy and selective IgA deficiency.

Authors:  M A French
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-15

8.  An investigation into the effect of the IgG antibody system on the susceptibility of IgA-deficient patients to respiratory tract infections.

Authors:  M A French; G Harrison
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

9.  Immunoglobulin G subclass responses to mycobacterial lipoarabinomannan in HIV-infected and non-infected patients with tuberculosis.

Authors:  C T Da Costa; S Khanolkar-Young; A M Elliott; K M Wasunna; K P McAdam
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

10.  Antibody levels after regular childhood vaccinations in the immunological screening of children with recurrent otitis media.

Authors:  Selma P Wiertsema; Elisabeth A M Sanders; Reinier H Veenhoven; Niels Van Heerbeek; Susan van den Hof; Guy A M Berbers; Ger T Rijkers
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.